Literature DB >> 18550922

Invasive and noninvasive correlations of B-type natriuretic peptide in patients with heart failure due to Chagas cardiomyopathy.

Fábio Vilas-Boas1, Gilson Soares Feitosa, Milena B P Soares, Joel Alves Pinho-Filho, Thais Nascimento, Marcos M Barojas, Marcus V S Andrade, Ricardo Ribeiro-Dos-Santos, Edimar Bocchi.   

Abstract

Heart failure due to Chagas cardiomyopathy (HFCC) differs from failure with other etiologies because of the occurrence of intense inflammatory infiltrate and right ventricle compromise. This article investigates correlations of B-type natriuretic peptide (BNP) levels with parameters of severity in HFCC. Twenty-eight patients and 8 normal controls underwent heart catheterization and clinical and laboratory analyses. BNP levels were higher in patients with HFCC (P<.0001) and correlated with New York Heart Association (NYHA) class; right atrial pressure; wedge pressure; cardiac output; levels of serum sodium, hemoglobin, urea, and tumor necrosis factor-alpha; and ejection fraction. Interferon-gamma and transforming growth factor-beta did not correlate with BNP level. The authors conclude that BNP levels are elevated in patients experiencing HFCC, irrespective of NYHA class, and that the occurrence of HFCC correlates with severity of disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18550922     DOI: 10.1111/j.1751-7133.2008.08166.x

Source DB:  PubMed          Journal:  Congest Heart Fail        ISSN: 1527-5299


  7 in total

Review 1.  Chronic Chagas' heart disease: a disease on its way to becoming a worldwide health problem: epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine.

Authors:  Silvia Gilka Muñoz-Saravia; Annekathrin Haberland; Gerd Wallukat; Ingolf Schimke
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

2.  Efficacy and Safety of Granulocyte-Colony Stimulating Factor Therapy in Chagas Cardiomyopathy: A Phase II Double-Blind, Randomized, Placebo-Controlled Clinical Trial.

Authors:  Carolina T Macedo; Ticiana F Larocca; Márcia Noya-Rabelo; Roque Aras; Cristiano R B Macedo; Moisés I Moreira; Alessandra C Caldas; Jorge A Torreão; Victor M A Monsão; Clarissa L M Souza; Juliana F Vasconcelos; Milena R Bezerra; Daniela P Petri; Bruno S F Souza; Antônio G F Pacheco; André Daher; Ricardo Ribeiro-Dos-Santos; Milena B P Soares
Journal:  Front Cardiovasc Med       Date:  2022-06-09

Review 3.  Clinical and echocardiographic predictors of mortality in chagasic cardiomyopathy--systematic review.

Authors:  Clodoval de Barros Pereira Júnior; Brivaldo Markman Filho
Journal:  Arq Bras Cardiol       Date:  2014-06-06       Impact factor: 2.000

4.  Predictors of low cardiac output in decompensated severe heart failure.

Authors:  Marcelo Eidi Ochiai; Juliano Novaes Cardoso; Kelly Regina Novaes Vieira; Marcelo Villaça Lima; Euler Cristovan Ochiai Brancalhao; Antonio Carlos Pereira Barretto
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

Review 5.  Biomarkers in cardiology--part 1--in heart failure and specific cardiomyopathies.

Authors: 
Journal:  Arq Bras Cardiol       Date:  2014-11-28       Impact factor: 2.000

6.  Correlation of transforming growth factor-β1 and tumour necrosis factor levels with left ventricular function in Chagas disease.

Authors:  Eduardo Ov Curvo; Roberto R Ferreira; Fabiana S Madeira; Gabriel F Alves; Mayara C Chambela; Veronica G Mendes; Luiz Henrique C Sangenis; Mariana C Waghabi; Roberto M Saraiva
Journal:  Mem Inst Oswaldo Cruz       Date:  2018-02-19       Impact factor: 2.743

7.  TGF-β Polymorphisms Are a Risk Factor for Chagas Disease.

Authors:  Roberto Rodrigues Ferreira; Fabiana da Silva Madeira; Gabriel Farias Alves; Mayara da Costa Chambela; Eduardo de Oliveira Vaz Curvo; Aline Dos Santos Moreira; Renata Almeida de Sá; Leila Mendonça-Lima; Pedro Hernan Cabello; Sabine Bailly; Jean-Jacques Feige; Tania Cremonini Araujo-Jorge; Roberto Magalhães Saraiva; Mariana Caldas Waghabi
Journal:  Dis Markers       Date:  2018-02-18       Impact factor: 3.434

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.